British Columbia Cancer Agency

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Feasibility Study of MRI Imaging on Parotid Gland Stimulation

Not Applicable

Conditions: Parotid Neoplasms

Interventions: Device: MRI
Other: Citric acid
Other: Gadovist

First Posted Date: 2014-11-19

Last Posted Date: 2016-11-28

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 10

Registration Number: NCT02294838

Locations: 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada

Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer

Phase 2

Conditions: Metastatic Castration-Resistant Prostatic Cancer

Interventions: Drug: cabazitaxel
Drug: Abiraterone
Drug: Enzalutamide 160mg daily (oral)

First Posted Date: 2014-10-02

Last Posted Date: 2017-12-06

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 120

Registration Number: NCT02254785

Locations: 🇨🇦
BCCA - Kelowna, Kelowna, British Columbia, Canada
🇦🇺
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
🇨🇦
Durham Regional Cancer Centre (Lakeridge Health), Oshawa, Ontario, Canada

and more 12 locations

Trial of Argon Plasma Coagulation Versus APC and APC and Hemospray in the Treatment of Radiation Proctitis

Not Applicable

Conditions: Rectal Bleeding

Interventions: Other: Hemospray

First Posted Date: 2014-09-09

Last Posted Date: 2014-09-09

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 20

Registration Number: NCT02233933

Locations: 🇨🇦
British Columbia Cancer Clinic, Vancouver, British Columbia, Canada

Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases

Not Applicable

Completed

Conditions: Brain Metastases

Interventions: Radiation: Single-fraction radiotherapy
Radiation: Whole-brain radiotherapy

First Posted Date: 2014-08-20

Last Posted Date: 2020-05-20

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 20

Registration Number: NCT02220491

Locations: 🇨🇦
British Columbia Cancer Agency, Vancouver, British Columbia, Canada

The Oncopanel Pilot (TOP) Study

Completed

Conditions: Colorectal Cancer Metastatic
Advanced Non-Small Cell Lung Carcinoma
Patients With Diagnosed Malignancies Being Considered for Clinical Trials
Advanced Melanoma
Gastrointestinal Stromal Tumors

First Posted Date: 2014-06-24

Last Posted Date: 2017-04-14

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 432

Registration Number: NCT02171286

Locations: 🇨🇦
BC Cancer Agency - Centre for the Southern Interior, Kelowna, British Columbia, Canada
🇨🇦
Abbotsford Centre, BC Cancer Agency, Abbotsford, British Columbia, Canada
🇨🇦
Fraser Valley Centre, BC Cancer Agency, Surrey, British Columbia, Canada

and more 2 locations

Personalized Oncogenomics (POG) Program of British Columbia

Not Applicable

Recruiting

Conditions: Advanced Cancers
Cancers That Cannot be Treated With Curative Intent
Metastatic Cancers

Interventions: Genetic: Genome sequencing

First Posted Date: 2014-06-04

Last Posted Date: 2021-01-28

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 5000

Registration Number: NCT02155621

Locations: 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada

Sequencing Abiraterone and Enzalutamide in mCRPC

Phase 2

Completed

Conditions: Metastatic Castration-Resistant Prostate Cancer

Interventions: Drug: Abiraterone acetate
Drug: Enzalutamide

First Posted Date: 2014-04-29

Last Posted Date: 2020-08-07

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 202

Registration Number: NCT02125357

Locations: 🇨🇦
BC Cancer Agency - Vancouver Centre, Vancouver, British Columbia, Canada
🇨🇦
BC Cancer Agency - Southern Interior, Kelowna, British Columbia, Canada
🇨🇦
Vancouver Prostate Centre, Vancouver, British Columbia, Canada

and more 4 locations

Living Well on Androgen Deprivation Therapy

Not Applicable

Withdrawn

Conditions: Prostate Cancer

Interventions: Behavioral: Exercise Sessions
Behavioral: Nutrition Education
Behavioral: Peer Support Volunteer

First Posted Date: 2014-04-09

Last Posted Date: 2021-07-29

Lead Sponsor: British Columbia Cancer Agency

Registration Number: NCT02108613

Locations: 🇨🇦
BC Cancer Agency, Victoria, British Columbia, Canada

Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients

Not Applicable

Completed

Conditions: Nonsmall Cell Lung Cancer

Interventions: Device: ALK qPCR assay

First Posted Date: 2013-12-12

Last Posted Date: 2017-08-08

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 166

Registration Number: NCT02010047

Locations: 🇨🇦
BC Cancer Agency-Abbotsford Centre, Abbotsford, British Columbia, Canada
🇨🇦
BC Cancer Agency-Centre for the North, Prince George, British Columbia, Canada
🇨🇦
BC Cancer Agency, Frase Valley Centre, Surrey, British Columbia, Canada

and more 4 locations

Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR Brachytherapy

Not Applicable

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Radiation: HDR
Radiation: LDR

First Posted Date: 2013-09-06

Last Posted Date: 2024-04-12

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 190

Registration Number: NCT01936883

Locations: 🇨🇦
British Columbia Cancer Agency Center for the Southern Interior, Kelowna, British Columbia, Canada

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy